Literature DB >> 25488115

[Interim results for the Patients' Rights Act and Infection Protection Act].

C-D Heidecke1, J Jaklin, B Konradt, A Mangold, V Sänger, H Siebert.   

Abstract

BACKGROUND: The Patient Rights Act has converted court rulings into legal paragraphs. Two new aspects have been introduced: the duty to hand over a copy of the signed written consent form to the patient (in which detailed recommendations are offered) and the obligation of a thorough documentation of findings and treatments within patient files. In addition the legislators, through the Joint Federal Committee (Gemeinsamer Bundesausschuss, GBA) have made the introduction of clinical risk management mandatory. The Infection Protection Act and its regulations have elevated the prerequisites of hygiene within hospitals and private practices with a parallel increase in liability. RESULTS AND DISCUSSION: Both laws and regulations offer no reference as to who (and to what extent) is financially responsible for the excessive increase in personnel costs, which are as yet not included in the German diagnosis-related groups (G-DRG) system. Despite all additional measures within the area of risk management, mistakes (avoidable or unavoidable) will nevertheless occur. In order to avoid longstanding legal battles the authors recommend an open and rapid communication with the patient and family. The wall of silence should be a thing of the past.

Entities:  

Mesh:

Year:  2014        PMID: 25488115     DOI: 10.1007/s00104-014-2790-2

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

1.  [Nosocomial infections in Germany. What are the numbers, based on the estimates for 2006?].

Authors:  P Gastmeier; C Geffers
Journal:  Dtsch Med Wochenschr       Date:  2008-05       Impact factor: 0.628

2.  [How many nosocomial infections are avoidable?].

Authors:  P Gastmeier; F Brunkhorst; M Schrappe; W Kern; C Geffers
Journal:  Dtsch Med Wochenschr       Date:  2010-01-14       Impact factor: 0.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.